Expand chart
Data: Institute of International Finance; Chart: Axios Visuals

Despite strong performances from both U.S. and Chinese stocks this year, emerging markets have not seen significant inflows in debt or equity. EM currencies, bonds and equity markets have also broadly lagged their U.S. counterparts.

Investors have been talking themselves hoarse about attractive EM valuations since late 2018 but haven't been buying. Typically, investors flock to EM in times of risk seeking, as they tend to rise more than mature markets like the U.S. or Europe.

What's happening: The cause appears to be the sell-off in August and September as Argentina and Turkey looked to be in danger of massive implosions, leading to broad selling of most EM assets.

  • Losses amounted to nearly $40 billion for investors who held Argentine assets and "most real money inflows were captive and unable to leave," says Elina Ribakova, deputy chief economist at the Institute of International Finance.
  • That's left investors largely unable to put fresh capital to work buying up EM assets this year.
  • Worse, Argentina and Turkey again are looking vulnerable.

Why it matters: "The positioning overhang means no smooth sailing for emerging markets, even with a dovish Fed shift," Ribakova tells Axios. "Asset managers already own lot of 'problematic' emerging market assets ... In this environment it is hard for EM to rally."

Go deeper: Emerging markets' dollar debt threatens global growth

Go deeper

Miriam Kramer, author of Space
11 mins ago - Science

The next environmental crisis could be in space

Illustration: Aïda Amer/Axios

An unexpected frontier is facing calls for new environmental regulations and cleanup: outer space.

Why it matters: Space junk clutters up orbits and poses an urgent threat to weather, security, communications and other satellites. Long-term, you can’t live or work in space if trash is literally slamming into you.

40 mins ago - Health

Axios-Ipsos poll: Trump's sickness makes him harder to trust

Data: Axios/Ipsos poll; Note: ±3.3% margin of error; Chart: Axios Visuals

Large shares of women, seniors and independents now say they're less likely to trust President Trump for accurate information about COVID-19 since he caught it himself, according to the latest installment of the Axios/Ipsos Coronavirus Index.

The big picture: Week 28 of our national survey has most Americans rejecting ideas that Trump has floated around hydroxychloriquine as a virus treatment, how herd immunity works or any imminent availability of a vaccine.

NY Post story goes massive on social media despite crackdowns

Data: NewsWhip; Chart: Naema Ahmed/Axios

Facebook and Twitter's frantic attempts to stop the spread of the New York Post's Hunter Biden story didn't prevent the article from becoming the top story about the election on those platforms last week, according to data from NewsWhip.

Why it matters: The data shows that even swift, aggressive content suppression may not be swift or aggressive enough to keep down a story with as much White House backing and partisan fuel as this one.